8/4/26 +4% since 7/1

Market participants navigate high volatility in the semiconductor and AI sectors, balancing short positions on overvalued stocks like Micron and Palantir against long-term growth projections. Trading strategies emphasize the Kelly criterion to optimize bet sizing and avoid the catastrophic risks associated with Martingale-style doubling down. Analysis of recent earnings calls reveals aggressive growth targets, such as SpaceX’s trillion-dollar revenue ambition by 2030, while simultaneously scrutinizing the technical validity of clinical trials for heart failure treatments like Leveosimendan. The discussion highlights the disconnect between speculative market rallies and underlying fundamental data, particularly in AI-driven infrastructure. By dissecting complex hemodynamic data and corporate financial disclosures, the session underscores the necessity of disciplined risk management and rigorous data verification in an environment prone to irrational exuberance and market manipulation.